BPMC logo

Blueprint Medicines (BPMC) Price To Sales Ratio

PS Ratio

15.35
-0.51-3.22%

25 min ago


Summary


Performance

BPMC PS Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherBPMCvaluationmetrics:

PS Ratio Formula

P/S =  
Market capitalization
TTM Revenue

BPMC PS Ratio Trends

PeriodPeriodPS ratioPS ratioPricePriceMarket capMarket capTTM revenueTTM revenue
todaytoday-3.2%-3.2%-3.2%+19.7%
1 m1 month+9.9%+9.9%+9.9%-
3 m3 months+1.9%+1.9%+1.9%+19.7%
6 m6 months-2.3%+16.6%+17.0%-
ytdytd+19.9%+19.9%+19.9%-
1 y1 year-19.6%+34.8%+40.0%+100.9%
5 y5 years-69.2%+70.7%+100.9%+92.5%

BPMC PS Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-9.2%12.79+20.0%
3 m3-month16.91-9.2%12.76+20.3%
6 m6-month17.37-11.6%12.05+27.4%
1 y1-year24.60-37.6%12.05+27.4%
3 y3-year27.59-44.4%9.01+70.4%
5 y5-year67.32-77.2%5.73+167.9%
alltimeall time1493.62-99.0%5.73+167.9%

Blueprint Medicines PS Ratio History

DateValue
2025
15.35(+19.9%)
2024
12.80(-44.0%)
2023
22.86(+86.9%)
2022
12.23(-65.2%)
2021
35.18(+330.6%)
DateValue
2020
8.17(-86.2%)
2019
59.35(+11.3%)
2018
53.32(-65.2%)
2017
153.37(+358.5%)
2016
33.45(-46.5%)
2015
62.54

FAQ

  • What is Blueprint Medicines price to sales ratio?
  • What is the all time high PS ratio for Blueprint Medicines?
  • What is BPMC price to sales ratio year-to-date change?
  • What is Blueprint Medicines PS ratio year-on-year change?

What is Blueprint Medicines price to sales ratio?

The current PS ratio of BPMC is 15.35

What is the all time high PS ratio for Blueprint Medicines?

Blueprint Medicines all-time high price to sales ratio is 1493.62

What is BPMC price to sales ratio year-to-date change?

Blueprint Medicines price to sales ratio has changed by +2.55 (+19.92%) since the beginning of the year

What is Blueprint Medicines PS ratio year-on-year change?

Over the past year, BPMC price to sales ratio has changed by -3.75 (-19.63%)